MSS mCRC | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,208 results for “MSS mCRC”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Active, not recruiting

Nivolumab+Ipilimumab+RT in MSS mCRC

32 participants · First posted Oct 5, 2020

BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC

13 participants · First posted Jan 2, 2019

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

71 participants · First posted Mar 23, 2022

PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC

40 participants · First posted Jan 16, 2024

PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC

56 participants · First posted Feb 22, 2018

Identification of New Patient Stratification Tools in MSS RAS mt mCRC

29 participants · First posted Oct 9, 2018

Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

176 participants · First posted Mar 14, 2023

Not yet recruiting

Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

10 participants · First posted Mar 20, 2026

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

52 participants · First posted Aug 1, 2023

Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC)

36 participants · First posted Sep 19, 2024

Page 1 of 506